| Danny Trammel Hood, MD | |
|
300 N College St, Greenville, AL 36037-2025 | |
| (334) 382-2681 | |
| (334) 383-9884 |
| Full Name | Danny Trammel Hood |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 48 Years |
| Location | 300 N College St, Greenville, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851331128 | NPI | - | NPPES |
| 000008875 | Medicaid | AL | |
| 51008875 | Other | AL | BLUE CROSS BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 0007855 (Alabama) | Secondary |
| 207R00000X | Internal Medicine | 00007855 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| The Health Care Authority Of The City Of Greenville- Lv Stabler Hospital | Greenville, AL | Hospital |
| Entity Name | Nes Tennessee, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437606605 PECOS PAC ID: 3678472040 Enrollment ID: O20161031002328 |
News Archive
Since its discovery as a protein that gets specifically released in response to brain injury, ciliary neurotrophic factor (CNTF) has prompted much interest as a potential therapeutic agent.
An advisory panel for the Food and Drug Administration (FDA) in the U.S. has recommended that the drug-coated stents used in patients with cardiovascular disease should carry a warning.
For women of mixed racial or ethnic backgrounds, a new method for measuring bone health may improve the odds of correctly diagnosing their risk of osteoporosis and bone fractures, according to a UCLA-led study.
In a comprehensive analysis of samples from 107 aged human brains, researchers at the Allen Institute for Brain Science, UW Medicine and Kaiser Permanente Washington Health Research Institute have discovered details that will help researchers better understand the biological bases for Alzheimer's disease and dementia in older populations.
YM BioSciences Inc. announced today that, in connection with its previously announced public offering for total net proceeds before expenses of US $37,650,000, the underwriters have exercised in full their Over-Allotment Option to purchase an additional 3,750,000 common shares of YM at US $1.60 per share for additional net proceeds of US $5,665,000.
› Verified 5 days ago
| Entity Name | Lv Stabler Primary Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871003533 PECOS PAC ID: 7719246586 Enrollment ID: O20180124002028 |
News Archive
Since its discovery as a protein that gets specifically released in response to brain injury, ciliary neurotrophic factor (CNTF) has prompted much interest as a potential therapeutic agent.
An advisory panel for the Food and Drug Administration (FDA) in the U.S. has recommended that the drug-coated stents used in patients with cardiovascular disease should carry a warning.
For women of mixed racial or ethnic backgrounds, a new method for measuring bone health may improve the odds of correctly diagnosing their risk of osteoporosis and bone fractures, according to a UCLA-led study.
In a comprehensive analysis of samples from 107 aged human brains, researchers at the Allen Institute for Brain Science, UW Medicine and Kaiser Permanente Washington Health Research Institute have discovered details that will help researchers better understand the biological bases for Alzheimer's disease and dementia in older populations.
YM BioSciences Inc. announced today that, in connection with its previously announced public offering for total net proceeds before expenses of US $37,650,000, the underwriters have exercised in full their Over-Allotment Option to purchase an additional 3,750,000 common shares of YM at US $1.60 per share for additional net proceeds of US $5,665,000.
› Verified 5 days ago
| Entity Name | Rmcca Clinic B, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275184848 PECOS PAC ID: 3072957406 Enrollment ID: O20240214000173 |
News Archive
Since its discovery as a protein that gets specifically released in response to brain injury, ciliary neurotrophic factor (CNTF) has prompted much interest as a potential therapeutic agent.
An advisory panel for the Food and Drug Administration (FDA) in the U.S. has recommended that the drug-coated stents used in patients with cardiovascular disease should carry a warning.
For women of mixed racial or ethnic backgrounds, a new method for measuring bone health may improve the odds of correctly diagnosing their risk of osteoporosis and bone fractures, according to a UCLA-led study.
In a comprehensive analysis of samples from 107 aged human brains, researchers at the Allen Institute for Brain Science, UW Medicine and Kaiser Permanente Washington Health Research Institute have discovered details that will help researchers better understand the biological bases for Alzheimer's disease and dementia in older populations.
YM BioSciences Inc. announced today that, in connection with its previously announced public offering for total net proceeds before expenses of US $37,650,000, the underwriters have exercised in full their Over-Allotment Option to purchase an additional 3,750,000 common shares of YM at US $1.60 per share for additional net proceeds of US $5,665,000.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Danny Trammel Hood, MD Po Box 398, Greenville, AL 36037-0398 Ph: (334) 382-6864 | Danny Trammel Hood, MD 300 N College St, Greenville, AL 36037-2025 Ph: (334) 382-2681 |
News Archive
Since its discovery as a protein that gets specifically released in response to brain injury, ciliary neurotrophic factor (CNTF) has prompted much interest as a potential therapeutic agent.
An advisory panel for the Food and Drug Administration (FDA) in the U.S. has recommended that the drug-coated stents used in patients with cardiovascular disease should carry a warning.
For women of mixed racial or ethnic backgrounds, a new method for measuring bone health may improve the odds of correctly diagnosing their risk of osteoporosis and bone fractures, according to a UCLA-led study.
In a comprehensive analysis of samples from 107 aged human brains, researchers at the Allen Institute for Brain Science, UW Medicine and Kaiser Permanente Washington Health Research Institute have discovered details that will help researchers better understand the biological bases for Alzheimer's disease and dementia in older populations.
YM BioSciences Inc. announced today that, in connection with its previously announced public offering for total net proceeds before expenses of US $37,650,000, the underwriters have exercised in full their Over-Allotment Option to purchase an additional 3,750,000 common shares of YM at US $1.60 per share for additional net proceeds of US $5,665,000.
› Verified 5 days ago
Dr. Kanu J Patel, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 45 Medical Arts Ct, Ste 1, Greenville, AL 36037 Phone: 334-382-5564 Fax: 334-382-9289 | |
Cecelia Camblin Hermann, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 E Commerce St, Greenville, AL 36037 Phone: 334-382-1522 Fax: 334-382-1562 | |
Dr. Chandra Shekar, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 302 Paul Stabler Drive, Greenville, AL 36037 Phone: 334-382-0530 Fax: 334-382-0498 |